Imbria Pharmaceuticals to Participate in the UBS Biotechnology Private Company Virtual Symposium
15. September 2022 08:00 ET
|
Imbria Pharmaceuticals Inc.
BOSTON, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced...